학술논문
Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
Document Type
Correspondence
Author
Source
In ESMO Open February 2022 7(1)
Subject
Language
ISSN
2059-7029